24 y.o. with Severe Palpitations on Steroids – Clinical Case Study

A twenty four year old man presents with severe palpitations that occur only on steroids. Several cycles of selective androgen receptor modulators are described before stronger drugs were used. Later cycles include high dose testosterone plus anavar, followed by a symptom free break. A repeat cycle triggers severe palpitations, and premature ventricular contractions are diagnosed without deeper context. A withdrawal period follows, and another attempt with high testosterone and possible sarms brings symptoms back again. A rushed visit with a cardiology office leads to a confusing suggestion for an invasive procedure. The case highlights that incomplete disclosure and incomplete history can derail appropriate evaluation.

Past rhythm history becomes central because childhood supraventricular tachycardia and atrial flutter are described. Sports participation was limited earlier in life, yet specialty electrophysiology evaluation never occurred. Family history includes mitral valve prolapse and hypertension, which adds context for rhythm vulnerability. Current vital signs are reassuring with a low resting heart rate and normal blood pressure at baseline. Chemistry, kidney function, thyroid, glucose, and standard blood counts are described as normal. Estradiol is described as elevated while tamoxifen is being used in a recovery attempt. The combination suggests symptoms are not simply from general illness, but from rhythm triggers during exposure.

Medication history includes metoprolol prescribed without full steroid disclosure or full rhythm history review. Nebivolol is discovered through online research and is described as sometimes better tolerated than metoprolol. The plan emphasizes proper evaluation rather than self prescribing based on scattered internet discussions. Referral is directed toward electrophysiology, a cardiology subspecialty focused on diagnosing arrhythmias precisely. Holter monitoring and rhythm capture are discussed, yet mapping may be needed when symptoms vanish off cycle. Catheter ablation is described as a potential treatment if a reentrant circuit or accessory pathway is confirmed. Closing guidance encourages safe decision making, clear disclosure, and avoiding future cycles without specialist input.